Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05679505

VAGUS NERVE STIMULATION FOR POST COVID-19 SYNDROME

Conditions: Long COVID, Vagus Nerve Stimulations, Heart Rates, Autonomic Nervous System Disorders

Sex: All
Ages: 18 Years – 45 Years
Healthy volunteers: 1
Phase: NA
Enrollment: 40
Sponsor: Bahçeşehir University

Location: Turkey

Summary

The aim of this study is to increase parasympathetic activity and decrease the severity of symptoms by providing vagal stimulation with the t-VNS method in order to suppress the increased sympathetic activity in patients with prolonged Covid symptoms.The main question[s] it aims to answer are:Question 1:Is left ear transcutaneous vagus nerve stimulation effective in suppressing the symptoms of patients in Post Covid syndrome?Question 2:Is bilateral auricular transcutaneous vagus nerve stimulation effective in suppressing the symptoms of patients in Post Covid syndrome?A 5-minute heart rate variability measurement will be performed to measure the effectiveness of vagus nerve stimulation in participants.HRV is a non-invasive method used to evaluate ANS activity and is a measure of heart rate change over a period of time

Eligibility Criteria

Inclusion Criteria:Being 18 years or olderExperiencing at least one of the post-covid symptoms for 12 weeks or longerExclusion Criteria:Considering that the female reproductive hormones level in the body and menstrual cycle may affect the ANS in female patients, female participants in perimenopausal, post-menopausal and pregnancy conditions were excluded from the study.Participants who used medication for the treatment of ANS dysfunction in the last six months were also excluded from the study.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05679505). StuddyBuddy aggregates publicly available trial information.